ArticleTherapeutic advances in drug safety2024

Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database.

Dongxuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.